NewEdge Wealth LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 5,030 shares of the medical research company’s stock, valued at approximately $668,000.
Other institutional investors have also modified their holdings of the company. Great Lakes Advisors LLC bought a new position in shares of Agilent Technologies in the second quarter valued at $297,000. Danske Bank A S acquired a new position in shares of Agilent Technologies in the 2nd quarter worth $32,556,000. Diversify Advisory Services LLC acquired a new stake in shares of Agilent Technologies during the second quarter worth $446,000. Wealthfront Advisers LLC raised its position in shares of Agilent Technologies by 13.2% during the second quarter. Wealthfront Advisers LLC now owns 22,930 shares of the medical research company’s stock worth $3,046,000 after purchasing an additional 2,682 shares during the period. Finally, Meeder Advisory Services Inc. lifted its holdings in shares of Agilent Technologies by 15.1% during the second quarter. Meeder Advisory Services Inc. now owns 8,850 shares of the medical research company’s stock valued at $1,176,000 after purchasing an additional 1,159 shares during the last quarter.
Wall Street Analysts Forecast Growth
A has been the subject of a number of recent analyst reports. TD Cowen increased their price target on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. HSBC reduced their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Finally, Piper Sandler initiated coverage on Agilent Technologies in a report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price for the company. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $160.24.
Agilent Technologies Stock Performance
A stock opened at $159.25 on Friday. The firm has a 50 day simple moving average of $137.57 and a 200 day simple moving average of $126.23. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.51. The stock has a market cap of $44.98 billion, a P/E ratio of 31.98, a P/E/G ratio of 2.81 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.
Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 6.05 earnings per share for the current fiscal year.
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Read More
- Five stocks we like better than Agilent Technologies
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
